SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-20-006421
Filing Date
2020-09-11
Accepted
2020-09-11 16:30:09
Documents
13
Period of Report
2020-09-11

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_091120.htm 6-K 13182
2 EXHIBIT 99.1 exh_991.htm EX-99.1 17604
3 GRAPHIC exh991_01.jpg GRAPHIC 68112
4 GRAPHIC exh991_02.jpg GRAPHIC 143305
5 GRAPHIC exh991_03.jpg GRAPHIC 66883
6 GRAPHIC exh991_04.jpg GRAPHIC 53028
7 GRAPHIC exh991_05.jpg GRAPHIC 70737
8 GRAPHIC exh991_06.jpg GRAPHIC 108219
9 GRAPHIC exh991_07.jpg GRAPHIC 92504
10 GRAPHIC exh991_08.jpg GRAPHIC 56445
11 GRAPHIC exh991_09.jpg GRAPHIC 66191
12 GRAPHIC exh991_10.jpg GRAPHIC 27188
13 GRAPHIC exh991_11.jpg GRAPHIC 77114
  Complete submission text file 0001171843-20-006421.txt   1172085
Mailing Address OSTERGADE 24A, 1 COPENHAGEN G7 1100
Business Address OSTERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36686 | Film No.: 201171297
SIC: 2834 Pharmaceutical Preparations